Suchergebnis | Hamburg Open Science

Facetten

3 Einträge gefunden

Assessment of imatinib as first-line treatment of chronic myeloid leukemia:10-year survival results of the randomized CML study IV and impact of non-CML determinants
2017 - Forschungsinformationssystem des UKE
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
2017 - Forschungsinformationssystem des UKE
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)
2014 - Forschungsinformationssystem des UKE